Continue to site >
Trending ETFs

Name

As of 06/01/2026

Price

Aum/Mkt Cap

YIELD

Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.

Exp Ratio

Expense ratio is the fund’s total annual operating expenses, including management fees, distribution fees, and other expenses, expressed as a percentage of average net assets.

Watchlist

T. Rowe Price Health Care ETF

TMED | Active ETF

$31.29

$20.1 M

0.52%

$0.16

0.44%

Vitals

YTD Return

5.3%

1 yr return

N/A

3 Yr Avg Return

N/A

5 Yr Avg Return

N/A

Net Assets

$20.1 M

Holdings in Top 10

44.6%

52 WEEK LOW AND HIGH

$31.7
$23.61
$31.75

Expenses

OPERATING FEES

Expense Ratio 0.44%

SALES FEES

Front Load N/A

Deferred Load N/A

TRADING FEES

Turnover N/A

Redemption Fee N/A


Min Investment

Standard (Taxable)

N/A

IRA

N/A


Fund Classification

Fund Type

Exchange Traded Fund


Name

As of 06/01/2026

Price

Aum/Mkt Cap

YIELD

Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.

Exp Ratio

Expense ratio is the fund’s total annual operating expenses, including management fees, distribution fees, and other expenses, expressed as a percentage of average net assets.

Watchlist

T. Rowe Price Health Care ETF

TMED | Active ETF

$31.29

$20.1 M

0.52%

$0.16

0.44%

TMED - Profile

Distributions

  • YTD Total Return 5.3%
  • 3 Yr Annualized Total Return N/A
  • 5 Yr Annualized Total Return N/A
  • Capital Gain Distribution Frequency N/A
  • Net Income Ratio N/A
DIVIDENDS
  • Dividend Yield 0.5%
  • Dividend Distribution Frequency Other

Fund Details

  • Legal Name
    T. Rowe Price Health Care ETF
  • Fund Family Name
    TROWEPRICE
  • Inception Date
    Jun 12, 2025
  • Shares Outstanding
    N/A
  • Share Class
    N/A
  • Currency
    USD
  • Domiciled Country
    US

Fund Description

p id="xdx_A8B_eoef--StrategyNarrativeTextBlock_zdlfTtAQ9nCf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"span id="xdx_90D_eoef--StrategyPortfolioConcentration_c20260225__20260225__dei--LegalEntityAxis__custom--S000092023Member_zLQBDSyqutL7"The fund normally invests at least 80% of its net assets (plus any borrowings for investment purposes) in the securities of health care companies./span The fund defines health care companies as companies engaged in health care innovations, such as developing new and effective therapies; pharmaceuticals; biotechnology; life sciences tools and services; managed health care; and/or health care equipment, supplies, providers, services, distributors, and facilities. The fund references the MSCI GICS (Global Industry Classification Standard) Health Care sector to identify such companies. Any derivatives that provide exposure to the investment focus suggested by the fund’s name, or to one or more market risk factors associated with the investment focus suggested by the fund’s name, are counted (as applicable) toward compliance with the fund’s 80% investment policy./p p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/p p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0" /p p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/p p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"As a fundamental policy, the fund will concentrate (invest more than 25% of its net assets) in health care companies./p p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0" /p p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"The majority of the fund will be invested in equity securities, such as common stocks. While most assets are typically invested in U.S. common stocks, the fund may invest in foreign stocks in keeping with its objective./p p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0" /p p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"The fund uses fundamental, bottom-up analysis and may invest in companies of any market capitalization. The adviser may use both growth and value approaches in selecting investments for the fund./p p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0" /p p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"The fund is nondiversified, which means it may invest a greater percentage of its assets in a particular issuer than is permissible for a diversified fund./p p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0" /p
Read More

TMED - Performance

Return Ranking - Trailing

Period TMED Return Category Return Low Category Return High Rank in Category (%)
YTD 5.3% N/A N/A N/A
1 Yr N/A N/A N/A N/A
3 Yr N/A* N/A N/A N/A
5 Yr N/A* N/A N/A N/A
10 Yr N/A* N/A N/A N/A

* Annualized

Return Ranking - Calendar

Period TMED Return Category Return Low Category Return High Rank in Category (%)
2025 N/A N/A N/A N/A
2024 N/A N/A N/A N/A
2023 N/A N/A N/A N/A
2022 N/A N/A N/A N/A
2021 N/A N/A N/A N/A

Total Return Ranking - Trailing

Period TMED Return Category Return Low Category Return High Rank in Category (%)
YTD 5.3% N/A N/A N/A
1 Yr N/A N/A N/A N/A
3 Yr N/A* N/A N/A N/A
5 Yr N/A* N/A N/A N/A
10 Yr N/A* N/A N/A N/A

* Annualized

Total Return Ranking - Calendar

Period TMED Return Category Return Low Category Return High Rank in Category (%)
2025 N/A N/A N/A N/A
2024 N/A N/A N/A N/A
2023 N/A N/A N/A N/A
2022 N/A N/A N/A N/A
2021 N/A N/A N/A N/A

TMED - Holdings

Concentration Analysis

TMED Category Low Category High TMED % Rank
Net Assets 20.1 M N/A N/A N/A
Number of Holdings 109 N/A N/A N/A
Net Assets in Top 10 9.03 M N/A N/A N/A
Weighting of Top 10 44.58% N/A N/A N/A

Top 10 Holdings

  1. ELI LILLY + CO COMMON STOCK 14.48%
  2. UNITEDHEALTH GROUP INC COMMON STOCK USD.01 6.54%
  3. THERMO FISHER SCIENTIFIC INC COMMON STOCK USD1.0 4.59%
  4. GILEAD SCIENCES INC COMMON STOCK USD.001 4.14%
  5. ABBOTT LABORATORIES COMMON STOCK 3.91%
  6. DANAHER CORP COMMON STOCK USD.01 2.73%
  7. MEDTRONIC PLC COMMON STOCK USD.1 2.24%
  8. ALNYLAM PHARMACEUTICALS INC COMMON STOCK USD.01 2.06%
  9. STRYKER CORP COMMON STOCK USD.1 2.00%
  10. DYNE THERAPEUTICS INC COMMON STOCK USD.0001 1.88%

Asset Allocation

Weighting Return Low Return High TMED % Rank
Stocks
99.76% N/A N/A N/A
Cash
0.60% N/A N/A N/A
Preferred Stocks
0.00% N/A N/A N/A
Other
0.00% N/A N/A N/A
Convertible Bonds
0.00% N/A N/A N/A
Bonds
0.00% N/A N/A N/A

Stock Sector Breakdown

Weighting Return Low Return High TMED % Rank
Utilities
0.00% N/A N/A N/A
Technology
0.00% N/A N/A N/A
Real Estate
0.00% N/A N/A N/A
Industrials
0.00% N/A N/A N/A
Healthcare
0.00% N/A N/A N/A
Financial Services
0.00% N/A N/A N/A
Energy
0.00% N/A N/A N/A
Communication Services
0.00% N/A N/A N/A
Consumer Defense
0.00% N/A N/A N/A
Consumer Cyclical
0.00% N/A N/A N/A
Basic Materials
0.00% N/A N/A N/A

Stock Geographic Breakdown

Weighting Return Low Return High TMED % Rank
US
99.51% N/A N/A N/A
Non US
0.25% N/A N/A N/A

TMED - Expenses

Operational Fees

TMED Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Expense Ratio 0.44% N/A N/A N/A
Management Fee 0.44% N/A N/A N/A
12b-1 Fee N/A N/A N/A N/A
Administrative Fee N/A N/A N/A N/A

Sales Fees

TMED Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Front Load N/A N/A N/A N/A
Deferred Load N/A N/A N/A N/A

Trading Fees

TMED Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Max Redemption Fee N/A N/A N/A N/A

Related Fees

Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.

TMED Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Turnover N/A N/A N/A N/A

TMED - Distributions

Dividend Yield Analysis

TMED Category Low Category High TMED % Rank
Dividend Yield 0.52% N/A N/A N/A

Dividend Distribution Analysis

TMED Category Low Category High Category Mod
Dividend Distribution Frequency Other

Net Income Ratio Analysis

TMED Category Low Category High TMED % Rank
Net Income Ratio N/A N/A N/A N/A

Capital Gain Distribution Analysis

TMED Category Low Category High Capital Mode
Capital Gain Distribution Frequency

Distributions History

View More +

TMED - Fund Manager Analysis

Tenure Analysis

Category Low Category High Category Average Category Mode
N/A N/A N/A N/A